Russell-Jones D - Search Results

1

Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans.

Pedersen C, Ijaz UZ, Gallagher E, Horton F, Ellis RJ, Jaiyeola E, Duparc T, Russell-Jones D, Hinton P, Cani PD, La Ragione RM, Robertson MD. Pedersen C, et al. Physiol Rep. 2018 Apr;6(7):e13649. doi: 10.14814/phy2.13649. Physiol Rep. 2018. PMID: 29611319 Free PMC article.

2

Fatty acid flux and oxidation are increased by rimonabant in obese women.

Backhouse K, Sarac I, Shojaee-Moradie F, Stolinski M, Robertson MD, Frost GS, Bell JD, Thomas EL, Wright J, Russell-Jones D, Umpleby AM. Backhouse K, et al. Metabolism. 2012 Sep;61(9):1220-3. doi: 10.1016/j.metabol.2012.02.012. Epub 2012 Mar 24. Metabolism. 2012. PMID: 22445512 Clinical Trial.

3

Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome.

Robertson MD, Wright JW, Loizon E, Debard C, Vidal H, Shojaee-Moradie F, Russell-Jones D, Umpleby AM. Robertson MD, et al. J Clin Endocrinol Metab. 2012 Sep;97(9):3326-32. doi: 10.1210/jc.2012-1513. Epub 2012 Jun 28. J Clin Endocrinol Metab. 2012. PMID: 22745235 Free article. Clinical Trial.

4

Effects of three weeks of mild sleep restriction implemented in the home environment on multiple metabolic and endocrine markers in healthy young men.

Robertson MD, Russell-Jones D, Umpleby AM, Dijk DJ. Robertson MD, et al. Metabolism. 2013 Feb;62(2):204-11. doi: 10.1016/j.metabol.2012.07.016. Epub 2012 Sep 15. Metabolism. 2013. PMID: 22985906 Free article. Clinical Trial.

5

Efficacy of increased resistant starch consumption in human type 2 diabetes.

Bodinham CL, Smith L, Thomas EL, Bell JD, Swann JR, Costabile A, Russell-Jones D, Umpleby AM, Robertson MD. Bodinham CL, et al. Endocr Connect. 2014 Apr 15;3(2):75-84. doi: 10.1530/EC-14-0036. Print 2014. Endocr Connect. 2014. PMID: 24671124 Free PMC article.

6

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.

Nobes JP, Langley SE, Klopper T, Russell-Jones D, Laing RW. Nobes JP, et al. BJU Int. 2012 May;109(10):1495-502. doi: 10.1111/j.1464-410X.2011.10555.x. Epub 2011 Sep 20. BJU Int. 2012. PMID: 21933330 Clinical Trial.

7

Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.

Bode BW, Bowering K, Russell-Jones D. Bode BW, et al. Diabetes Care. 2018 Mar;41(3):e29-e30. doi: 10.2337/dci17-0051. Diabetes Care. 2018. PMID: 29463670 No abstract available.

8

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.

Whyte MB, Shojaee-Moradie F, Sharaf SE, Jackson NC, Fielding B, Hovorka R, Mendis J, Russell-Jones D, Umpleby AM. Whyte MB, et al. J Clin Endocrinol Metab. 2019 Feb 1;104(2):359-368. doi: 10.1210/jc.2018-01176. J Clin Endocrinol Metab. 2019. PMID: 30215735 Free PMC article. Clinical Trial.

9

Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.

Herring RA, Shojaee-Moradie F, Garesse R, Stevenage M, Jackson N, Fielding BA, Mendis A, Johnsen S, Umpleby AM, Davies M, Russell-Jones DL. Herring RA, et al. Diabetes Care. 2020 Sep;43(9):2128-2136. doi: 10.2337/dc19-2579. Epub 2020 Jul 8. Diabetes Care. 2020. PMID: 32641376 Clinical Trial.

10

100 years of physiology, discrimination and wonder.

Russell-Jones D, Herring R. Russell-Jones D, et al. Diabet Med. 2021 Dec;38(12):e14642. doi: 10.1111/dme.14642. Epub 2021 Aug 17. Diabet Med. 2021. PMID: 34251695 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page